100 years of insulin: from discovery to delivery
The long history of insulin discovery and its development for treating diabetes is marked with determination and serendipity, collaboration and controversy.
drug discovery
CRISPR advances cardiovascular disease research
CRISPR gene editing directly and indirectly drives advances in cardiovascular disease therapeutic development.
Accelerating Drug Discovery with High-Throughput and High-Content Screens
LIVE October 26th, 2021 at 11:00 AM ET
Experts will discuss recent advances in screening strategies to more efficiently identify therapeutic candidates for infectious diseases such as schistosomiasis and COVID-19.
Experts will discuss recent advances in screening strategies to more efficiently identify therapeutic candidates for infectious diseases such as schistosomiasis and COVID-19.
A Balancing Act: Drug Discovery for Cancer
LIVE September 22nd, 2021 at 2:30 PM ET
Scientists will discuss how they identify and design new cell-based anticancer treatments and how they balance the need for potency with the specter of side effects.
Scientists will discuss how they identify and design new cell-based anticancer treatments and how they balance the need for potency with the specter of side effects.
Special Report: Seeking intelligence
Beyond the buzz, is AI just another research tool?
Small but Powerful: Small Molecule Drug Design
LIVE August 26th, 2021 at 11:00 AM ET
In this webinar, experts will discuss new approaches to identify small therapeutic candidates targeting diabetes and Alzheimer’s disease.
Lifelike systems
Organ-on-chip and tissue-on-chip models continue to advance drug discovery
Specifica sells antibody library platform to UCB
The Generation 3 Library Platform will boost UCB’s discovery efforts
